Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells

• Published in: Stem cells (Dayton, Ohio) Ohio), 2007-05, Vol.25 (5), p.1241-1251
• Main Authors: Fan, Vivian H., Au, Ada, Tamama, Kenichi, Littrell, Romie, Richardson, Llewellyn B., Wright, John W., Wells, Alan, Griffith, Linda G.
• Format: Article
• Language: English
• Subjects: Animals; Bone graft; Cell Death - drug effects; Cell death Cell spreading; Cell Movement - drug effects; Cell Survival - drug effects; Cytokines - pharmacology; Epidermal growth factor; Epidermal Growth Factor - pharmacology; Extracellular Signal-Regulated MAP Kinases - metabolism; Extracellular signal‐regulated protein kinase; Fas ligand; Fas Ligand Protein - pharmacology; Humans; Kinetics; Mesenchymal stem cells; Mesenchymal Stromal Cells - cytology; Mesenchymal Stromal Cells - drug effects; Mesenchymal Stromal Cells - enzymology; Mice; Phosphorylation - drug effects; Polymers - metabolism; Receptor, Epidermal Growth Factor - metabolism; Solubility - drug effects; Telomerase - metabolism; TNF-Related Apoptosis-Inducing Ligand - pharmacology; Tumor Necrosis Factors - metabolism
• ISSN: 1066-5099; 1549-4918
• DOI: 10.1634/stemcells.2006-0320

MSC can act as a pluripotent source of reparative cells during injury and therefore have great potential in regenerative medicine and tissue engineering. However, the response of MSC to many growth factors and cytokines is unknown. Many envisioned applications of MSC, such as treating large defects in bone, involve in vivo implantation of MSC attached to a scaffold, a process that creates an acute inflammatory environment that may be hostile to MSC survival. Here, we investigated cellular responses of MSC on a biomaterial surface covalently modified with epidermal growth factor (EGF). We found that surface‐tethered EGF promotes both cell spreading and survival more strongly than saturating concentrations of soluble EGF. By sustaining mitogen‐activated protein kinase kinase‐extracellular‐regulated kinase signaling, tethered EGF increases the contact of MSC with an otherwise moderately adhesive synthetic polymer and confers resistance to cell death induced by the proinflammatory cytokine, Fas ligand. We concluded that tethered EGF may offer a protective advantage to MSC in vivo during acute inflammatory reactions to tissue engineering scaffolds. The tethered EGF‐modified polymers described here could be used together with structural materials to construct MSC scaffolds for the treatment of hard‐tissue lesions, such as large bony defects. Disclosure of potential conflicts of interest is found at the end of this article.